vs
AtriCure, Inc.（ATRC）与DOMO, INC.（DOMO）财务数据对比。点击上方公司名可切换其他公司
AtriCure, Inc.的季度营收约是DOMO, INC.的1.8倍（$140.5M vs $79.4M），AtriCure, Inc.同比增速更快（13.1% vs -0.5%），AtriCure, Inc.自由现金流更多（$18.4M vs $1.1M），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs -0.5%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
ATRC vs DOMO — 直观对比
营收规模更大
ATRC
是对方的1.8倍
$79.4M
营收增速更快
ATRC
高出13.5%
-0.5%
自由现金流更多
ATRC
多$17.3M
$1.1M
两年增速更快
ATRC
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $79.4M |
| 净利润 | — | $-10.4M |
| 毛利率 | 75.0% | 74.2% |
| 营业利润率 | 1.8% | -8.7% |
| 净利率 | — | -13.1% |
| 营收同比 | 13.1% | -0.5% |
| 净利润同比 | — | 44.6% |
| 每股收益（稀释后） | $0.04 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCDOMO
| Q4 25 | $140.5M | $79.4M | ||
| Q3 25 | $134.3M | $79.7M | ||
| Q2 25 | $136.1M | $80.1M | ||
| Q1 25 | $123.6M | $78.8M | ||
| Q4 24 | $124.3M | $79.8M | ||
| Q3 24 | $115.9M | $78.4M | ||
| Q2 24 | $116.3M | $80.1M | ||
| Q1 24 | $108.9M | $80.2M |
净利润ATRCDOMO
| Q4 25 | — | $-10.4M | ||
| Q3 25 | $-267.0K | $-22.9M | ||
| Q2 25 | $-6.2M | $-18.1M | ||
| Q1 25 | $-6.7M | $-17.7M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $-7.9M | $-19.5M | ||
| Q2 24 | $-8.0M | $-26.0M | ||
| Q1 24 | $-13.3M | $-18.7M |
毛利率ATRCDOMO
| Q4 25 | 75.0% | 74.2% | ||
| Q3 25 | 75.5% | 74.8% | ||
| Q2 25 | 74.5% | 74.2% | ||
| Q1 25 | 74.9% | 74.4% | ||
| Q4 24 | 74.5% | 75.0% | ||
| Q3 24 | 74.9% | 74.3% | ||
| Q2 24 | 74.7% | 74.1% | ||
| Q1 24 | 74.7% | 76.3% |
营业利润率ATRCDOMO
| Q4 25 | 1.8% | -8.7% | ||
| Q3 25 | 0.2% | -9.1% | ||
| Q2 25 | -4.5% | -17.9% | ||
| Q1 25 | -4.8% | -15.6% | ||
| Q4 24 | -11.7% | -13.9% | ||
| Q3 24 | -6.4% | -18.5% | ||
| Q2 24 | -6.2% | -26.8% | ||
| Q1 24 | -10.0% | -16.6% |
净利率ATRCDOMO
| Q4 25 | — | -13.1% | ||
| Q3 25 | -0.2% | -28.8% | ||
| Q2 25 | -4.5% | -22.5% | ||
| Q1 25 | -5.5% | -22.4% | ||
| Q4 24 | — | -23.5% | ||
| Q3 24 | -6.8% | -24.9% | ||
| Q2 24 | -6.9% | -32.5% | ||
| Q1 24 | -12.2% | -23.3% |
每股收益（稀释后）ATRCDOMO
| Q4 25 | $0.04 | $-0.25 | ||
| Q3 25 | $-0.01 | $-0.56 | ||
| Q2 25 | $-0.13 | $-0.45 | ||
| Q1 25 | $-0.14 | $-0.45 | ||
| Q4 24 | $-0.33 | $-0.48 | ||
| Q3 24 | $-0.17 | $-0.51 | ||
| Q2 24 | $-0.17 | $-0.69 | ||
| Q1 24 | $-0.28 | $-0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | — |
| 总债务越低越好 | — | $124.2M |
| 股东权益账面价值 | $491.9M | $-191.9M |
| 总资产 | $654.2M | $201.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCDOMO
| Q4 25 | $167.4M | — | ||
| Q3 25 | $147.9M | — | ||
| Q2 25 | $117.8M | $47.2M | ||
| Q1 25 | $99.9M | $45.3M | ||
| Q4 24 | $122.7M | — | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $114.0M | $61.2M | ||
| Q1 24 | $106.0M | $60.9M |
总债务ATRCDOMO
| Q4 25 | — | $124.2M | ||
| Q3 25 | $61.9M | $121.9M | ||
| Q2 25 | $61.9M | $119.7M | ||
| Q1 25 | $61.9M | $117.7M | ||
| Q4 24 | — | $115.6M | ||
| Q3 24 | $61.9M | $115.2M | ||
| Q2 24 | $61.9M | $114.1M | ||
| Q1 24 | $61.9M | $113.5M |
股东权益ATRCDOMO
| Q4 25 | $491.9M | $-191.9M | ||
| Q3 25 | $476.5M | $-191.5M | ||
| Q2 25 | $464.5M | $-178.7M | ||
| Q1 25 | $454.6M | $-177.2M | ||
| Q4 24 | $461.0M | $-171.2M | ||
| Q3 24 | $465.0M | $-166.4M | ||
| Q2 24 | $462.1M | $-163.5M | ||
| Q1 24 | $456.3M | $-153.5M |
总资产ATRCDOMO
| Q4 25 | $654.2M | $201.6M | ||
| Q3 25 | $635.4M | $195.7M | ||
| Q2 25 | $608.8M | $189.7M | ||
| Q1 25 | $591.6M | $214.3M | ||
| Q4 24 | $609.3M | $190.2M | ||
| Q3 24 | $615.1M | $197.8M | ||
| Q2 24 | $597.3M | $204.4M | ||
| Q1 24 | $591.6M | $225.7M |
负债/权益比ATRCDOMO
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $3.4M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $1.1M |
| 自由现金流率自由现金流/营收 | 13.1% | 1.4% |
| 资本支出强度资本支出/营收 | 1.1% | 2.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $48.3M | $9.9M |
8季度趋势，按日历期对齐
经营现金流ATRCDOMO
| Q4 25 | $20.0M | $3.4M | ||
| Q3 25 | $26.7M | $3.4M | ||
| Q2 25 | $21.6M | $4.0M | ||
| Q1 25 | $-11.0M | $8.9M | ||
| Q4 24 | $5.8M | $-13.7M | ||
| Q3 24 | $20.0M | $-6.2M | ||
| Q2 24 | $7.4M | $1.9M | ||
| Q1 24 | $-21.0M | $5.4M |
自由现金流ATRCDOMO
| Q4 25 | $18.4M | $1.1M | ||
| Q3 25 | $24.1M | $1.0M | ||
| Q2 25 | $19.0M | $1.0M | ||
| Q1 25 | $-13.2M | $6.7M | ||
| Q4 24 | $3.1M | $-16.2M | ||
| Q3 24 | $16.4M | $-8.4M | ||
| Q2 24 | $5.0M | $-625.0K | ||
| Q1 24 | $-23.8M | $2.9M |
自由现金流率ATRCDOMO
| Q4 25 | 13.1% | 1.4% | ||
| Q3 25 | 18.0% | 1.3% | ||
| Q2 25 | 13.9% | 1.3% | ||
| Q1 25 | -10.7% | 8.5% | ||
| Q4 24 | 2.5% | -20.3% | ||
| Q3 24 | 14.1% | -10.7% | ||
| Q2 24 | 4.3% | -0.8% | ||
| Q1 24 | -21.9% | 3.6% |
资本支出强度ATRCDOMO
| Q4 25 | 1.1% | 2.9% | ||
| Q3 25 | 1.9% | 2.9% | ||
| Q2 25 | 2.0% | 3.7% | ||
| Q1 25 | 1.8% | 2.8% | ||
| Q4 24 | 2.2% | 3.2% | ||
| Q3 24 | 3.1% | 2.8% | ||
| Q2 24 | 2.1% | 3.2% | ||
| Q1 24 | 2.5% | 3.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
